Company News

HemoSonics’ Quantra^® Hemostasis Analyzer provides comprehensive blood analysis that details critical bleeding disorders and helps clinicians manage patients back into hemostasis. The Quantra System has the broadest range of FDA-cleared indications for use in its category and is cleared for use with arterial and venous blood samples in cardiac, trauma, liver, and major orthopedic surgery […]

Honored by Fast Company in the medical device category for its easy-to-operate Quantra^® Hemostasis System that provides fast, comprehensive whole-blood coagulation analysis at the point of care, HemoSonics joins Abbott, Amgen, Bristol Myers Squib, Novartis, Scopio Labs and others as the recipient of this prestigious award DURHAM, NC – March 20, 2024 – HemoSonics, a […]

Honored for excellence as a finalist in the health, medical, and biotechnology category, HemoSonics’ Quantra Hemostasis System helps hospitals and healthcare workers with fast, easy to interpret and comprehensive whole blood coagulation analysis typically in 15 minutes or less DURHAM, NC – February 13, 2024 – HemoSonics, LLC, a medical device company focused on acute […]

HemoSonics joins the ranks of previous healthcare category winners, including Blue Shield of California and Accuhealth, in an awards program that recognizes innovative organizations and people. DURHAM, N.C. – January 10, 2024 – HemoSonics, LLC, a medical device company focused on acute bleeding management, today announced that its Quantra Hemostasis System with QStat Cartridge has […]

HemoSonics wins in product launch and business expansion categories as more hospitals adopt its Quantra^® Hemostasis System for acute bleeding management.DURHAM, N.C., Oct. 5, 2023 /PRNewswire/ — HemoSonics, a medical device company delivering individualized diagnostic solutions for acute care bleeding and the management of coagulation, announced today that the company has won in both the […]

Contract awarded for products that bring improvement to the healthcare industry; HemoSonics’ Quantra Hemostasis System provides comprehensive whole blood coagulation analysis at the point of care in less than 15 minutes. DURHAM, N.C. – August 3, 2023 – HemoSonics^®, a medical device technology company focused on acute bleeding management, today announced its Quantra^® Hemostasis System […]

Next-Generation point-of-care whole blood hemostasis system now covers the broadest range of clinical indications in the U.S. to date. Durham, North Carolina – November, 30, 2022 – HemoSonics, LLC, a leading medical device company delivering individualized diagnostic solutions for Patient Blood Management (PBM), announced today that it has received 510(k) market clearance from the U.S. […]

Newly appointed Medical Director, Bruce Spiess, MD, FAHA to moderate the educational session “Listening to the Blood: An Update on the Quantra^® System, the Latest Technology in the Management of Critical Bleeding” Clinical tools on display to provide actionable information to guide the management of critical bleeding enabling clinicians to choose the right treatment in […]

Charlottesville, VA, January 19, 2021 – HemoSonics welcomes the January 14th guidance of the US Food and Drug Administration (FDA) that broadens the use of viscoelastic coagulation analyzers for hospital patient healthcare settings in response to COVID-19. The FDA guidance is intended, for the duration of the COVID-19 public health emergency, to expand the availability […]

Charlottesville, VA – September 10, 2020 – HemoSonics announced today that its Quantra Desktop Remote Viewer Software (QDRV) has received a 510(k) clearance from the FDA. The QDRV enables remote access to its flagship product, the Quantra QPlus System. The Quantra System provides rapid, actionable coagulation results at the point of care – now viewable […]